Results 151 to 160 of about 118,448 (336)

Pharmacology of reproduction (report 25): Effect of bromocriptine (CB-154), a dopamine agonist on the stimulatory effect of gonadotropin on testicular testosterone levels by the rat

, 1981
Masanao Hirai, Yoshiko Masubuchi, Akiyo Uematsu, Toshio Kumai, K Komoriyama   +4 more
openalex   +1 more source

Dopamine agonists both stimulate and inhibit prolactin release in GH4ZR7 cells [PDF]

, 1999
Annisa Chang, Shin Sh
openalex   +1 more source

Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Evidence suggests that female gender represents a risk factor for the development of motor/nonmotor fluctuations and dyskinesia in Parkinson's disease (PD). So far, no prospective study has analyzed this aspect in relation to the introduction of levodopa treatment.
Maria Teresa Pellecchia, Marina Picillo, Maria Claudia Russillo, Marianna Amboni, Gennarina Arabia, Laura Avanzino, Margherita Canesi, Alessia Catania, Roberto Ceravolo, Calogero Edoardo Cicero, Roberto Cilia, Isabel Colangelo, Giovanna Dati, Rosa De Micco, Anna De Rosa, Alessio Di Fonzo, Roberto Eleopra, Vincenza Fetoni, Barbara Garavaglia, Augusta Giglio, Martina Giuntini, Federica Invernizzi, Giulia Lazzeri, Roberta Marchese, Alessandra Nicoletti, Claudio Pacchetti, Celeste Panteghini, Manuela Pilleri, Fabiana Radicati, Chiara Reale, Cesa Scaglione, Andrea Soricelli, Fabrizio Stocchi, Alessandro Tessitore, Laura Vacca, Maria Antonietta Volontè, Graziella Volpi, Roberta Zangaglia, Francesco Amato, Carlo Ricciardi, Michela Russo, Paolo Barone   +41 more
wiley   +1 more source

Phosphodiesterase 10A (PDE10A): Regulator of Dopamine Agonist-Induced Gene Expression in the Striatum. [PDF]

Cells, 2022
Bonate R, Kurek G, Hrabak M, Patterson S, Padovan-Neto F, West AR, Steiner H.   +6 more
europepmc   +1 more source

Effects of dopaminergic agonists on rotational behavior and striatal dopamine metabolism following unilateral electrical stimulation of the substantia nigra in the rat

, 1983
Sunao Hata, Hiroshi Watanabe, Kazuo Watanabe   +2 more
openalex   +1 more source

Erratum to Current status of dopamine agonists in Parkinson’s disease [PDF]

, 1996
J L Montastruc, Olivier Rascol, Jean‐Michel Sénard   +2 more
openalex   +1 more source

Levodopa‐Carbidopa Intestinal Gel in an Outpatient Setting: A 10‐Year Experience

Movement Disorders Clinical Practice, EarlyView.
Alessandro Magliozzi, Nicholas Feugas, Yu Yan Poon, Taline Naranian, Louis Liu, Yvonne Tse, Anthony E. Lang, Alfonso Fasano   +7 more
wiley   +1 more source

Management of Anxiety in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Anxiety is a common, distressing, hard‐to‐diagnose and hard‐to‐treat symptom in Parkinson's disease. No formal guidelines exist to assist management. Objective We provide a pragmatic guide to detecting and managing anxiety in Parkinson's disease.
Alex J. Berry, Harry Costello, Silvia Jesús, Gary Price, Ashwani Jha   +4 more
wiley   +1 more source

Increased prevalence of high Body Mass Index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma

Swiss Medical Weekly, 2006
DL Goede, RS Hauser
doaj   +1 more source

Altered Pain Processing Associated with Administration of Dopamine Agonist and Antagonist in Healthy Volunteers. [PDF]

Brain Sci, 2022
Martin SL, Jones AKP, Brown CA, Kobylecki C, Whitaker GA, El-Deredy W, Silverdale MA.   +6 more
europepmc   +1 more source